Human Cardiac Stem Cells Isolated from Atrial Appendages Stably Express c-kit
Open Access
- 28 November 2011
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 6 (11), e27719
- https://doi.org/10.1371/journal.pone.0027719
Abstract
The in vivo studies of myocardial infarct using c-kit+/Lin− cardiac stem cells (CSCs) are still in the early stage with margin or no beneficial effects for cardiac function. One of the potential reasons may be related to the absence of fully understanding the properties of these cells both in vitro and in vivo. In the present study, we aimed to systematically examine how CSCs adapted to in vitro cell processes and whether there is any cell contamination after long-term culture. Human CSCs were enzymatically isolated from the atrial appendages of patients. The fixed tissue sections, freshly isolated or cultured CSCs were then used for identification of c-kit+/Lin− cells, detection of cell contamination, or differentiation of cardiac lineages. By specific antibody staining, we demonstrated that tissue sections from atrial appendages contained less than 0.036% c-kit+/Lin− cells. For the first time, we noted that without magnetic activated cell sorting (MACS), the percentages of c-kit+/Lin− cells gradually increased up to ∼40% during continuously culture between passage 2 to 8, but could not exceed >80% unless c-kit MACS was carried out. The resulting c-kit+/Lin− cells were negative for CD34, CD45, CD133, and Lin markers, but positive for KDR and CD31 in few patients after c-kit MACS. Lin depletion seemed unnecessary for enrichment of c-kit+/Lin− cell population. Following induced differentiation, c-kit+/Lin− CSCs demonstrated strong differentiation towards cardiomyocytes but less towards smooth and endothelial cells. We concluded that by using an enzymatic dissociation method, a large number, or higher percentage, of relative pure human CSCs with stable expression of c-kit+ could be obtained from atrial appendage specimens within ∼4 weeks following c-kit MACS without Lin depletion. This simple but cost-effective approach can be used to obtain enough numbers of stably-expressed c-kit+/Lin− cells for clinical trials in repairing myocardial infarction.Keywords
This publication has 71 references indexed in Scilit:
- Origins of Cardiac FibroblastsCirculation Research, 2010
- Cardiospheres Recapitulate a Niche-Like Microenvironment Rich in Stemness and Cell-Matrix Interactions, Rationalizing Their Enhanced Functional Potency for Myocardial RepairThe International Journal of Cell Cloning, 2010
- Origin of cardiac progenitor cells in the developing and postnatal heartJournal of Cellular Physiology, 2010
- Isolation and expansion of functionally-competent cardiac progenitor cells directly from heart biopsiesJournal of Molecular and Cellular Cardiology, 2010
- Identification of a coronary vascular progenitor cell in the human heartProceedings of the National Academy of Sciences of the United States of America, 2009
- c-kit cardiac progenitor cells: What is their potential?Proceedings of the National Academy of Sciences, 2009
- Notch1 regulates the fate of cardiac progenitor cellsProceedings of the National Academy of Sciences, 2008
- Stem cells in the heart: What's the buzz all about? Part 2: Arrhythmic risks and clinical studiesHeart Rhythm, 2008
- Stem cells in the heart: What's the buzz all about?—Part 1: Preclinical considerationsHeart Rhythm, 2008
- Human cardiac stem cellsProceedings of the National Academy of Sciences, 2007